SEC Form 4 · accession 0001209191-15-055527
CORCEPT THERAPEUTICS INC · CORT
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
David L Mahoney
Director
Period of report
Jun 18, 2015
Accepted (ET)
Jun 22, 2015 · 9:53 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001088856
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Common stock (Right to buy)F1 | $6.55 | Jun 18, 2015 | A | 30,000 | A | — | Jun 18, 2025 | Common stock | 30,000 | 30,000 | D |
Explanation of responses
- F1Exercisable with respect to 8.3334% of the total option shares on each monthly anniversary of June 18, 2015 so that the entirety of the option grant will vest on or before the date of Corcept's next Annual Meeting of Stockholders.